Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.

PURPOSE Oncogenic driver mutations are critical for lung cancer development and serve as therapeutic targets. However, their associations with environmental factors are not fully understood. We aimed to elucidate the relationship between tumor developmental biology and exposure to environmental factors. PATIENTS AND METHODS This was a prospective, multicenter, molecular epidemiology study. Eligible patients were those with newly diagnosed stages I to IIIB non-small-cell lung cancer (NSCLC) who underwent surgery. The tumors were examined for somatic mutations in 72 cancer-associated genes by targeted deep sequencing, estrogen receptor β (ERβ) expression using immunohistochemical staining, and infection with any of 37 types of human papillomavirus (HPV) using a polymerase chain reaction-based microarray system. Detailed information on patient demographics and environmental factors was obtained from a comprehensive questionnaire. RESULTS From July 2012 to December 2013, 957 patients were enrolled, and molecular analyses were performed on 876 samples (from 441 ever- and 435 never-smokers). Oncogenic driver mutations in P53 and KRAS increased proportionally with smoking status, whereas mutations in EGFR and SMAD4 decreased. KRAS mutations in smokers and SMAD4 mutations were observed more frequently in proportion to body mass index. TP53 and NFE2L2 mutations were observed more frequently in advanced NSCLC stages. As for never-smokers, no environmental factors were significantly associated with mutational changes. EGFR mutations and TP53 mutations were observed more frequently in women and in men, respectively. Mutations in these two genes were also potentially associated with ERβ expression. Only three patients (0.3%) were HPV positive. CONCLUSION The mutational spectrum is associated with smoking, body mass index, and other environmental factors, as well as with ERβ expression. Little association was observed between HPV and NSCLC.

[1]  William Pao,et al.  Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. , 2014, JAMA.

[2]  Leah E. Mechanic,et al.  EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[3]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[4]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[5]  Kenji Suzuki,et al.  A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients , 2013, PloS one.

[6]  T. Oyama,et al.  Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[8]  R. Saito,et al.  Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLC , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  Takeo Iwama,et al.  Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.

[10]  P. Schlag,et al.  Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.

[11]  Ronglai Shen,et al.  Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers , 2012, Clinical Cancer Research.

[12]  S. Ou,et al.  Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. , 2014, Lung cancer.

[13]  S. Peters,et al.  BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[15]  H. Saka,et al.  Rationale and design of the Japan molecular epidemiology for lung cancer study. , 2013, Clinical lung cancer.

[16]  S. Wacholder,et al.  Assessment of Human Papillomavirus in Lung Tumor Tissue , 2011, Journal of the National Cancer Institute.

[17]  H. Sasaki,et al.  Long Exposure of Environmental Tobacco Smoke Associated with Activating EGFR Mutations in Never-Smokers with Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.

[18]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[19]  Li Ding,et al.  Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.

[20]  H. Sasaki,et al.  Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. , 2011, Molecular medicine reports.

[21]  L. Diaz,et al.  Liquid biopsies: genotyping circulating tumor DNA. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  B. Qian,et al.  Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia , 2012, Nature Genetics.

[23]  I. Wistuba,et al.  Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation , 2009, Clinical Cancer Research.

[24]  Yong Soo Choi,et al.  Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Jee,et al.  Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Sasaki,et al.  Genotype analysis of the NRF2 gene mutation in lung cancer. , 2013, International journal of molecular medicine.

[27]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[28]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.